Table 1 The ratio of differentially methylated CpG sites in all CpGs tested
Group | All CpGs | Differentially methylation CpGs (%) | Non-differentially methylation CpGs (%) |
|---|---|---|---|
Adenoma | 485,512 (100%) | 65,535 (13.50%) | 419,977 (86.50%) |
Colorectal cancer | 485,512 (100%) | 39,571 (8.15%) | 445,941 (91.85%) |